Relation of Thrombolysis in Myocardial Infarction Frame Count to Invasively Measured Coronary Physiologic Indexes

Tatsuro Yamazaki1, Yuichi Saito2, Daichi Yamashita1

  • 1Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

PubMed

Insights

The thrombolysis in myocardial infarction frame count (TFC) is not a reliable indicator for diagnosing coronary microvascular dysfunction (CMD). This study found corrected TFC (cTFC) did not correlate well with invasive measures like coronary flow reserve (CFR) or index of microcirculatory resistance (IMR).

Area of Science:

  • Cardiology
  • Vascular Physiology
  • Diagnostic Imaging

Background:

  • International guidelines suggest elevated thrombolysis in myocardial infarction frame count (TFC) indicates coronary microvascular dysfunction (CMD).
  • The diagnostic accuracy of TFC, specifically corrected TFC (cTFC), for invasively confirmed CMD remains uncertain.
  • Invasive assessment of coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) are gold standards for CMD diagnosis.

Purpose of the Study:

  • To evaluate if a corrected TFC (cTFC) cutoff of >25, as per guidelines, accurately identifies coronary microvascular dysfunction (CMD).
  • To assess the correlation between cTFC and invasive physiological parameters (CFR, IMR) in patients without significant epicardial coronary artery disease.

Main Methods:

  • 137 patients without significant epicardial lesions underwent invasive coronary physiological assessment using thermodilution in the left anterior descending artery.
  • Corrected TFC (cTFC) was measured from coronary angiography.
  • Coronary microvascular dysfunction (CMD) was defined by abnormal CFR (≤2.0) and/or IMR (>25).

Main Results:

  • A corrected TFC (cTFC) >25 was present in 24.8% of patients, while CMD was diagnosed in 23.3%.
  • No significant difference in CMD rates was observed between patients with and without cTFC >25.
  • cTFC showed weak correlations with mean transit time and IMR, but no significant correlation with CFR; receiver operating characteristic analysis indicated poor diagnostic ability.

Conclusions:

  • In patients without obstructive epicardial coronary artery disease, corrected TFC (cTFC) is not diagnostic for coronary microvascular dysfunction (CMD).
  • Neither cTFC as a continuous variable nor the guideline-suggested cutoff of 25 effectively identifies abnormal CFR or IMR.
  • The findings do not support the use of cTFC for evaluating coronary microvascular dysfunction.